Sign in to view content

Intraocular Pressure Elevation Immediately Following High-Volume (0.07 mL-0.15 mL) vs Standard Volume (0.05 mL) Injections

Scott D Walter, MD, MSc, FASRS

Video
Published 2024

Related

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Episode 199: Nov/Dec 2019 Retinal Physician Preview: New Pathways for Dry AMD
Jayanth Sridhar, MD
Member Podcasts
2019

Category: Pharmacology

See more